Blebitis Management: A National Survey and Literature Review

Authors

  • Inês Mendo Ophthalmology Integrated Responsibility Center, Unidade Local de Saúde Almada-Seixal, Almada, Portugal https://orcid.org/0009-0007-6514-8267
  • Mariana Vaz Ophthalmology Integrated Responsibility Center, Unidade Local de Saúde Almada-Seixal, Almada, Portugal
  • João Vaz Ophthalmology Integrated Responsibility Center, Unidade Local de Saúde Almada-Seixal, Almada, Portugal
  • Tomás Loureiro Ophthalmology Integrated Responsibility Center, Unidade Local de Saúde Almada-Seixal, Almada, Portugal
  • Paula Telles Ophthalmology Integrated Responsibility Center, Unidade Local de Saúde Almada-Seixal, Almada, Portugal
  • Pedro Simões Ophthalmology Integrated Responsibility Center, Unidade Local de Saúde Almada-Seixal, Almada, Portugal
  • Nuno Campos Ophthalmology Integrated Responsibility Center, Unidade Local de Saúde Almada-Seixal, Almada, Portugal

DOI:

https://doi.org/10.48560/rspo.44956

Keywords:

Eye Infections, Bacterial/drug therapy, Eye Infections, Bacterial/etiology, Glaucoma/surgery, Postoperative Complications, Trabeculectomy/adverse effects

Abstract

INTRODUCTION: Filtering surgeries remain a cornerstone in the management of glaucoma. Although rare, blebitis represents a potentially severe complication that can compromise both surgical success and visual prognosis if not recognized and treated promptly. Management strategies vary widely, and no formal guidelines currently exist to direct therapy. In this context, the present study combines a brief literature review with a national survey to provide an updated overview of blebitis and to evaluate current trends in its management among glaucoma specialists in Portugal.

METHODS: An anonymous online survey consisting of 12 questions regarding the diagnosis and management of blebitis was distributed to glaucoma specialists in Portugal. The questionnaire addressed hospital admission, microbiological sampling, topical and systemic antibiotic use, corticosteroid and cycloplegic prescription, as well as criteria for addressing these cases as endophthalmitis. Responses were analyzed descriptively to identify patterns of practice and heterogeneity in management approaches. In parallel, a narrative review of the literature was conducted to summarize current evidence on incidence, risk factors, and therapeutic strategies.

RESULTS: A total of 33 responses were collected. Only 15.2% of glaucoma specialists reported admitting patients with isolated blebitis for inpatient treatment. Regarding antibiotic therapy, all specialists initiated topical treatment, with 72.7% preferring fortified eye drops containing ceftazidime and vancomycin. A minority opted for additional routes of antibiotic administration: intravitreal in 12.1%, subconjunctival in 9.1%, and intravenous in 6.1% of cases. Most specialists prescribed topical cycloplegics (75.8%) and topical corticosteroids (90.9%), although only 16.7% initiated corticosteroids at the time of diagnosis. Among respondents, 39.4% reported that they would only consider treating blebitis as endophthalmitis in the presence of vitreous involvement.

CONCLUSION: This combined literature review and national survey highlight significant variability in the management of blebitis among Portuguese glaucoma specialists, reflecting the absence of standardized guidelines. The findings underscore the need for consensus-based recommendations that may harmonize management strategies, improve patient safety, and optimize visual outcomes in this rare but sight-threatening complication.

Downloads

Download data is not yet available.

References

Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081-2090.

Rao A, Cruz RD. Trabeculectomy: does it have a future? Cureus. 2022;14:e27834. doi: 10.7759/cureus.27834.

Kandarakis SA, Doumazos L, Mitsopoulou D, Economou MA, Mylona I, Dimitriou C, et al. A Review on Pathogens and Necessary Diagnostic Work for Bleb-Related Infections (BRIs). Diagnostics. 2022;12:2075. doi: 10.3390/diagnostics12092075.

Yassin SA. Bleb-related infection revisited: a literature review. Acta Ophthalmol. 2016;94:122-34. doi: 10.1111/aos.12805.

Mac I, Soltau JB. Glaucoma-filtering bleb infections. Curr Opin Ophthalmol. 2003;14:91-4. doi: 10.1097/00055735-200304000-00007. P

Yang HY, Chi SC, Ko YC, Chen MJ, Kuang TM, Chang YF, et al. Bleb-related infection after primary trabeculectomy: medical chart reviews from 1993 to 2021. Br J Ophthalmol. 2023;108:58-64. doi: 10.1136/bjo-2022-321429.

Shoji N, Arakaki Y, Nakamoto K, Yamamoto T, Kuwayama Y; Collaborative Bleb-related Infection Incidence and Treatment Study Group. Efficacy of predetermined therapeutic measures against bleb-related infection in the Collaborative Bleb-related Infection Incidence and Treatment Study. Acta Ophthalmol. 2018;96:e229-36. doi: 10.1111/aos.13523.

Sharan S, Trope GE, Chipman M, Buys YM. Late-onset bleb infections: prevalence and risk factors. Can J Ophthalmol. 2009;44:279e83.

Soltau JB, Rothman RF, Budenz DL, Greenfield DS, Feuer W, Liebmann JM, et al. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol. 2000;118:338e42. doi: 10.1001/archoph.118.3.338.

Poulsen EJ, Allingham RR. Characteristics and risk factors of infections after glaucoma filtering surgery. J Glaucoma. 2000;9:438e43.

Sharan S, Trope GE, Chipman M, Buys YM. Late-onset bleb infections: prevalence and risk factors. Can J Ophthalmol. 2009;44:279e83. doi: 10.3129/i09-050.

Chiam PJ, Arashvand K, Shaikh A, James B. Management of blebitis in the United Kingdom: a survey. Br J Ophthalmol. 2011;96:38-41. doi: 10.1136/bjo.2010.200402.

Reynolds AC, Skuta GL, Monlux R, Johnson J. Management of blebitis by members of the American Glaucoma Society: a survey. J Glaucoma, 2001;10:340e7. doi: 10.1097/00061198-200108000-00015.

Robin AL, Ramakrishnan R, Krishnadas R, Smith SD, Katz JD, Selvaraj S, et al. A long-term dose response study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol. 1997;115:969e74. doi: 10.1001/archoph.1997.01100160139001.

Greenfield DS, Suner IJ, Miller MP, Kangas TA, Palmberg PF, Flynn HW Jr. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol. 1996;114:943e9. doi: 10.1001/archoph.1996.01100140151007.

DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120:297e300. doi: 10.1001/archoph.120.3.297.

Shigeeda T, Tomidokoro A, Chen YN, Shirato S, Araie M. Long-term follow-up of initial trabeculectomy with mitomycin C for primary open-angle glaucoma in Japanese patients. J Glaucoma 2006;15:195e9. doi: 10.1097/01.iig.0000212202.57029.45.

Ticho U, Ophir A. Late complications after glaucoma filtering surgery with adjunctive 5-fluorouracil. Am J Ophthalmol. 1993;115:506e10.

Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol. 1996;121:349e66.

Uchida S, Suzuki Y, Araie M, Shigeeda T, Hara T, Shirato S. Long-term follow-up of initial 5-fluorouracil trabeculectomy in primary open-angle glaucoma in Japanese patients. J Glaucoma. 2001;10:458e65. doi: 10.1097/00061198-200112000-00004.

Gocke DJ, Ponticas S, Pollack W. In vitro studies of the killing of clinical isolates by povidone-iodine solutions. J Hosp Infect. 1985;6:596e66.

Boes DA, Lindquist TD, Fritsche TR, Kalina RE. Effects of povidone-iodine chemical preparation and saline irrigation on the perilimbal flora. Ophthalmology. 1992;99:1569e74. doi: 10.1016/s0161-6420(92)31765-8.

Gregori NZ, Schiffman JC, Miller DM, Alfonso EC. Clinical trial of povidone-iodine (Betadine) versus placebo in the pretreatment of corneal ulcers. Cornea. 2006;25:558-63. doi: 10.1097/01.ico.0000214220.67872.b1.

Yamamoto T, Kuwayama Y, Kano K, Sawada A, Shoji N; Study Group for the Japan Glaucoma Society Survey of Blebrelated Infection. Clinical features of bleb-related infection: a 5-year survey in Japan. Acta Ophthalmol. 2013;91:619-24. doi: 10.1111/j.1755-3768.2012.02480.x.

Ciulla TA, Beck AD, Topping TM, Baker AS. Blebitis, early endophthalmitis, and late endophthalmitis after glaucoma-filtering surgery. Ophthalmology. 1997;104:986-95. doi: 10.1016/s0161-6420(97)30196-1.

Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002;109:985-91. doi: 10.1016/s0161-6420(02)00965-x.

Jacobs DJ, Leng T, Flynn HW Jr, Shi W, Miller D, Gedde SJ. Delayed-onset bleb-associated endophthalmitis: presentation and outcome by culture result. Clin Ophthalmol. 2011;5:739-44. doi: 10.2147/OPTH.S17975.

Leng T, Miller D, Flynn HW Jr, Jacobs DJ, Gedde SJ. Delayedonset bleb-associated endophthalmitis (1996-2008): causative organisms and visual acuity outcomes. Retina. 2011;31:344-52. doi: 10.1097/IAE.0b013e3181e09810.

Miller DM, Vedula AS, Flynn HW Jr, Miller D, Scott IU, Smiddy WE, et al. Endophthalmitis caused by Staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomes. Ophthalmol Surg Lasers Imaging. 2007;38:446e51.

Oliveira AD, D'Azevedo PA, Francisco W. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil. Cornea. 2007;26:194-8. doi: 10.1097/01.ico.0000248379.78777.f6.

Busbee BG, Recchia FM, Kaiser R, Nagra P, Rosenblatt B, Pearlman RB. Bleb-associated endophthalmitis. Clinical characteristics and visual outcomes. Ophthalmology. 2004;111:1495-503.

Brown MM, Sattarova V, Chanbour W, Hou J, Sheheitli H. Bleb Complications After XEN Gel Stent Implantation Linked to Mitomycin C. J Glaucoma. 2025;34:e51-5. doi: 10.1097/IJG.0000000000002588.

Kudsieh B, Almazan-Alonso E, Ruiz-Medrano J, Samaan M, Ruiz-Moreno JM. Staphylococcus capitus blebitis following preserflo microshunt implantation. J Glaucoma. 2025;34:e38-e40. doi: 10.1097/IJG.0000000000002578.

Downloads

Published

2026-09-27

How to Cite

Mendo, I., Vaz, M., Vaz, J., Loureiro, T., Telles, P., Simões, P., & Campos, N. (2026). Blebitis Management: A National Survey and Literature Review. Revista Sociedade Portuguesa De Oftalmologia, 50(3), 238–248. https://doi.org/10.48560/rspo.44956

Issue

Section

Original Article